Free Trial

Electromed (ELMD) Competitors

Electromed logo
$20.32 +0.67 (+3.41%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$20.60 +0.28 (+1.38%)
As of 05/27/2025 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ELMD vs. IRMD, EMBC, RXST, BBNX, CBLL, DCTH, AVNS, BFLY, BVS, and KIDS

Should you be buying Electromed stock or one of its competitors? The main competitors of Electromed include Iradimed (IRMD), Embecta (EMBC), RxSight (RXST), Beta Bionics (BBNX), CeriBell (CBLL), Delcath Systems (DCTH), Avanos Medical (AVNS), Butterfly Network (BFLY), Bioventus (BVS), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

Electromed vs.

Electromed (NYSE:ELMD) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings.

Electromed presently has a consensus target price of $38.00, indicating a potential upside of 87.01%. Iradimed has a consensus target price of $72.00, indicating a potential upside of 37.01%. Given Electromed's stronger consensus rating and higher probable upside, equities analysts plainly believe Electromed is more favorable than Iradimed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Electromed
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Iradimed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Electromed had 3 more articles in the media than Iradimed. MarketBeat recorded 4 mentions for Electromed and 1 mentions for Iradimed. Iradimed's average media sentiment score of 1.85 beat Electromed's score of 1.37 indicating that Iradimed is being referred to more favorably in the news media.

Company Overall Sentiment
Electromed Positive
Iradimed Very Positive

Iradimed received 236 more outperform votes than Electromed when rated by MarketBeat users. However, 92.59% of users gave Electromed an outperform vote while only 65.58% of users gave Iradimed an outperform vote.

CompanyUnderperformOutperform
ElectromedOutperform Votes
25
92.59%
Underperform Votes
2
7.41%
IradimedOutperform Votes
261
65.58%
Underperform Votes
137
34.42%

Iradimed has a net margin of 26.26% compared to Electromed's net margin of 11.34%. Iradimed's return on equity of 24.12% beat Electromed's return on equity.

Company Net Margins Return on Equity Return on Assets
Electromed11.34% 15.71% 13.37%
Iradimed 26.26%24.12%21.20%

Iradimed has higher revenue and earnings than Electromed. Electromed is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Electromed$61.44M2.77$5.15M$0.7925.72
Iradimed$75.15M8.89$19.23M$1.5533.90

Electromed has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.

40.8% of Electromed shares are held by institutional investors. Comparatively, 92.3% of Iradimed shares are held by institutional investors. 14.0% of Electromed shares are held by insiders. Comparatively, 36.8% of Iradimed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Iradimed beats Electromed on 14 of the 19 factors compared between the two stocks.

Get Electromed News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELMD vs. The Competition

MetricElectromedElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$170.40M$3.17B$5.38B$19.51B
Dividend YieldN/A1.80%5.28%3.91%
P/E Ratio27.0917.9327.0134.99
Price / Sales2.77193.58392.0635.83
Price / Cash41.3644.0938.2517.51
Price / Book3.983.826.774.77
Net Income$5.15M$94.03M$3.22B$1.02B
7 Day Performance-2.64%3.99%1.68%1.86%
1 Month Performance-11.15%17.06%6.96%5.74%
1 Year Performance43.40%-6.28%19.47%6.63%

Electromed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELMD
Electromed
0.9716 of 5 stars
$20.32
+3.4%
$38.00
+87.0%
+22.0%$170.40M$61.44M27.09160Positive News
IRMD
Iradimed
4.9069 of 5 stars
$54.21
+0.6%
$72.00
+32.8%
+24.0%$689.28M$75.15M36.14110Positive News
EMBC
Embecta
4.3527 of 5 stars
$11.62
-3.3%
$20.33
+75.0%
-14.2%$679.11M$1.08B11.621,900Gap Up
RXST
RxSight
2.7896 of 5 stars
$16.32
+15.0%
$37.90
+132.2%
-73.8%$663.20M$148.31M-19.66220Positive News
Gap Up
High Trading Volume
BBNX
Beta Bionics
N/A$15.10
+5.2%
$24.83
+64.5%
N/A$654.68M$69.83M0.00294Gap Down
CBLL
CeriBell
2.754 of 5 stars
$17.83
-0.8%
$32.50
+82.3%
N/A$644.43M$71.54M0.00N/APositive News
DCTH
Delcath Systems
3.2201 of 5 stars
$18.10
+5.8%
$22.75
+25.7%
+110.9%$630.35M$53.85M-13.4160Positive News
Analyst Revision
AVNS
Avanos Medical
2.6199 of 5 stars
$13.00
-0.8%
N/A-35.9%$601.17M$689.20M38.244,040Positive News
BFLY
Butterfly Network
2.4022 of 5 stars
$2.32
-1.3%
$4.00
+72.4%
+152.5%$573.71M$85.63M-5.04460Gap Up
BVS
Bioventus
3.189 of 5 stars
$6.93
+2.1%
$14.33
+106.8%
+2.5%$567.87M$567.70M-11.361,200Positive News
KIDS
OrthoPediatrics
4.6396 of 5 stars
$22.95
-0.5%
$35.83
+56.1%
-35.1%$557.39M$212.45M-18.66200Positive News

Related Companies and Tools


This page (NYSE:ELMD) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners